Author:
van Ede Elisabeth S.,Hoeks Marlijn P. A.,Hofland Jan,Linssen Vera D.,van Kuppevelt Toin H.,Versteeg Elly M.,Hafmans Theo G.,Diepstra Arjan,Kusters Benno,Vermorgen Sanne M. M.
Abstract
AbstractBackgroundNon-AT-III mediated heparin-resistance during CPB occurs by complex-forming with heparin-binding proteins. Currently, there are no specific recommendations for non-AT-III mediated heparin-resistance.Case presentationWe present a fatal case of a 70-yr-old male-patient undergoing cardiac-surgery in which refractory heparin-resistance was observed. The massive AL amyloidosis found at autopsy is thought to be responsible and illustrates that awareness and knowledge of the etiology and perioperative strategies of non-AT-III mediated heparin-resistance is important.ConclusionFor anticoagulation during cardiopulmonary bypass surgery in case of a non-AT-III medicated heparin resistance, we refer to the decision tree added to this manuscript and if necessary to consider direct thrombin inhibitors, such as bivalirudin or argatroban, as it bypasses the complexing pathway.
Publisher
Springer Science and Business Media LLC
Subject
Anesthesiology and Pain Medicine
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Thromboembolic and bleeding risk in cardiac amyloidosis;Journal of Thrombosis and Haemostasis;2024-09
2. Multiple drugs;Reactions Weekly;2023-07-22